Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Boceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Genotype 4 Chronic Hepatitis C Infection

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2014 by Theodor Bilharz Research Institute.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Mostafa Ibrahim, Theodor Bilharz Research Institute
ClinicalTrials.gov Identifier:
NCT01653236
First received: July 26, 2012
Last updated: December 25, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)